AEHG is a leveraged, single-stock ETF that seeks to deliver 200% (2x) of the daily price performance of Aehr Test Systems (AEHR), a Nasdaq-listed semiconductor capital equipment company, before fees and expenses. The fund carries a total expense ratio of 0.99% and is structured to reset its leverage daily.
Rather than holding a diversified basket of securities, AEHG obtains its exposure primarily through derivatives such as total return swaps referencing Aehr's common stock. As a result, the fund is effectively a concentrated, single-company position. Aehr designs and sells wafer-level test and burn-in systems, including its FOX family of products, used to stress-test and stabilize semiconductor devices across applications such as silicon carbide power chips, memory, processors, sensors, and photonic components used in artificial intelligence (AI).
This structure explains the fund's recent volatility. Because AEHG tracks a single, high-beta underlying security with two-times daily leverage, its price movement is a magnified, compounding reflection of Aehr's daily swings, with no offset from other sectors or holdings.
Over the last 30 days, AEHG fell from a closing level of roughly $3.07 to $1.72, a decline of approximately 44%. The move was not a single-day event; it unfolded through a sequence of sharp down days interspersed with short-lived rebounds, consistent with a leveraged instrument tracking a volatile underlying stock.
The broader quarterly picture is even steeper. Over the trailing three months, the fund declined from about $15.51 to $1.72, a loss of roughly 89%. This extended drawdown reflects both sustained downward pressure on Aehr's share price and the well-documented volatility drag that affects daily-reset leveraged products, which can lose value disproportionately when the underlying trades lower in a choppy, high-volatility pattern.
The dominant driver was a sharp selloff in AI- and semiconductor-related equities that swept through the sector during the period. Aehr, as a test-and-burn-in equipment supplier tied to AI chip demand, was caught in the broader risk-off move even as its fundamentals improved.
Aehr reported fiscal first-quarter 2027 results featuring revenue of $33.01 million, up roughly 200% year over year from $10.97 million, along with a return to profitability and a raised full-year revenue outlook of $150 million. Despite the strong report, the stock continued to slide. Analysts at Jefferies and Lake Street trimmed their price targets, to $140 and $90 respectively, while retaining Buy ratings, and elevated valuation multiples that had built up earlier in the year left the shares vulnerable to de-rating.
For AEHG, each down day in the underlying was doubled, and the cumulative effect of leverage on a declining, high-volatility asset compounded the loss beyond a simple two-times multiple of the underlying's cumulative move.
Over the trailing three months, AEHG's decline tracked a broader rotation away from richly valued, high-momentum semiconductor names. Aehr shares had surged earlier in the year, reaching a 52-week high above $140, before a sustained unwind in AI-related positioning and profit-taking pressured the stock back toward the low double digits.
Institutional money-flow data pointed to broad-based selling across investor categories, while insider transactions over the prior twelve months leaned heavily toward sales. The combination of multiple compression, sector-wide de-risking, and the mechanical decay of a daily-leveraged product drove the fund's roughly 89% quarterly decline, far exceeding the underlying's own percentage loss over the same span.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that lets investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. It is designed to surface trending securities, breakout candidates, and shifting market themes more efficiently than manual screening, while helping users compare instruments by sector exposure and market trends. For investors monitoring leveraged and thematic products, the screener offers a structured way to identify opportunities and reassess positioning as conditions evolve.
The path ahead for AEHG is tied almost entirely to Aehr Test Systems and, by extension, to the health of the AI and semiconductor capital-equipment cycle. Key factors to monitor include the pace of the anticipated burn-in systems ramp, customer order timing, and whether the raised revenue outlook is confirmed by actual bookings and backlog conversion.
Broader forces will also matter: the direction of AI-related capital spending, memory and power-semiconductor demand, interest-rate expectations, and investor appetite for high-multiple growth stocks. Because AEHG resets leverage daily, volatility itself is a material risk factor; extended sideways or choppy trading in the underlying can erode fund value even without a large net price decline. Investors should weigh these structural characteristics carefully alongside any view on the semiconductor sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.